Epidural administration of therapeutic compounds with sustained rate of release
A drug delivery system provides sustained-release delivery of therapeutic biologically active compounds administered epidurally. In the preferred embodiment the biologically active compound is an opioid, which is encapsulated within the non-concentric internal aqueous chambers or bilayers of multive...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
18.03.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A drug delivery system provides sustained-release delivery of therapeutic biologically active compounds administered epidurally. In the preferred embodiment the biologically active compound is an opioid, which is encapsulated within the non-concentric internal aqueous chambers or bilayers of multivesicular liposomes. The opioid is released over an extended period of time when the liposomes are introduced epidurally as a single dose for sustained analgesia. |
---|---|
Bibliography: | Application Number: EP20080017456 |